Literature DB >> 15780128

Opportunity and cost of sevelamer in dialysis patients.

Ghazali Abderrhamane, Demontis Renato, Fievet Patrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15780128     DOI： 10.1111/j.1523-1755.2005.247_5.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  1 in total

1.  K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?

Authors:  Mingxin Wei; Hulya Taskapan; Khaled Esbaei; Sarbjit Vanita Jassal; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006-12-11       Impact factor: 2.370
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.